CD4 and synovial sarcoma: Several high-throughput sequences of both SS patients and activated T cells were used in our previous study [17, 18], and we found that Gls1 was significantly upregulated in both sequencing datasets and could serve as a potential target to interfere with the abnormal metabolic state of CD4+ T cells upon the development of SS.